Scinai Immunotherapeutics Ltd. (SCNI) Institutional Ownership
Q1 2026 13F Data|Updated 2026-06-13
✨
Institutional ownership decreased this quarter (-26.37 pp), while top 10 holders maintain a highly concentrated 100.0% of value.
Institutional Ownership3.6%$15K total value · ▼ 26.37 pp vs prior quarter
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
Smart Money Score8 / 100Heavy Distribution
Based on ownership concentration, fund quality, buying/selling activity, conviction signals, and institutional trend.
Institutions & Flow4 holders-3 net flow (+0 / -3)
AI Insights & Key Takeaways
- Negative Institutional Flow (-3)
- Top 10 holders control 100.0% of institutional value
- No Insider Signal
Top Institutional Holders of SCNI
Ranked by reported Q1 2026 13F market value
Top 10 Holders
100.0%
Top 25 Holders
100.0%
Share of total reported institutional value in SCNI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | XTX Topco Ltd | 24K | $13K | -11.9% | 1.828% | 0.00% |
| 2 | RHUMBLINE ADVISERS | 2K | $1K | 0.0% | 0.143% | 0.00% |
| 3 | UBS Group AG | 919 | $524 | -47.4% | 0.070% | 0.00% |
| 4 | MORGAN STANLEY | 58 | $33 | 0.0% | 0.004% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in SCNI — a direct measure of their conviction.
Quarterly Institutional Activity
Filings activity in SCNI during Q1 2026, grouped by how each filer changed its position.
SCNI Institutional Ownership by Quarter
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 4 | 43% | 3.63% | 26.37 pp | $0M | 88% |
| Q4 2025 | 7 | +0.0% | 30.00% | 8.17 pp | $0M | 21% |
| Q3 2025 | 7 | +17% | 38.17% | +17.33 pp | $0M | +83% |
| Q2 2025 | 6 | +20% | 20.84% | +9.83 pp | $0M | +89% |
| Q1 2025 | 5 | +0.0% | 11.01% | 9.72 pp | $0M | 47% |
| Q4 2024 | 5 | 17% | 20.73% | +19.00 pp | $0M | +1100% |
| Q3 2024 | 6 | 40% | 1.73% | 11.59 pp | $0M | 87% |
| Q2 2024 | 10 | — | 13.32% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
SCNI — Frequently Asked Questions
Quick answers to the most common questions about buying SCNI stock.
What percentage of SCNI is owned by institutions?
Based on Q1 2026 13F filings, institutional ownership of Scinai Immunotherapeutics Ltd. stands at 3.6%, held across 4 reporting institutions.
Who is the largest institutional holder of SCNI?
XTX Topco Ltd is the largest reported institutional holder of SCNI, with approximately 24,041 shares worth $0.00B as of Q1 2026.
Is SCNI a hedge fund favorite?
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of SCNI.
What is SCNI's Smart Money Score?
Our composite Smart Money Score for SCNI is 8 out of 100 (Heavy Distribution). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
How many institutions bought SCNI this quarter?
0 institutions opened new positions in SCNI during Q1 2026, while 3 fully exited. 0 added to existing positions and 4 trimmed.
How is institutional ownership of SCNI changing?
SCNI institutional ownership fell by 26.37 percentage points quarter-over-quarter, with a net change of -3 holders.
How concentrated is SCNI ownership among the top holders?
The top 10 institutions account for 100.0% of all reported 13F value in SCNI, and the top 25 account for 100.0%.
Where does this SCNI institutional ownership data come from?
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.